Loss of dysbindin-1, a risk gene for schizophrenia, leads to impaired group 1 metabotropic glutamate receptor function in mice

Frontiers in Behavioral Neuroscience

Volumn 9, Issue , 2015, Pages

  Bhardwaj, Sanjeev K ^a   Ryan, Richard T ^a   Wong, Tak Pan ^a   Srivastava, Lalit K ^a  

^a DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

Author keywords

Animal model; Cognition; Hippocampus; Memory; Schizophrenia; Synaptic plasticity

Indexed keywords

3 CYANO N (1, 3 DIPHENYL1H PYRAZOL 5 YL BENZAMIDE); 3,5 DIHYDROXYPHENYLGLYCINE; DYSBINDIN; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 5; MITOGEN ACTIVATED PROTEIN KINASE 1; UNCLASSIFIED DRUG;

ADULT; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DTNBP1 GENE; ENZYME ACTIVATION; GENE; GENETIC RISK; GLUTAMATERGIC SYNAPSE; HIPPOCAMPAL CA1 REGION; LONG TERM DEPRESSION; LOSS OF FUNCTION MUTATION; MALE; MORRIS WATER MAZE TEST; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SPATIAL LEARNING; WESTERN BLOTTING;

EID: 84939534135     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2015.00072     Document Type: Article

References (49)

1. Anwyl, R. (2009). Metabotropic glutamate receptor-dependent long-term potentiation. Neuropharmacology 56, 735-740. doi: 10.1016/j.neuropharm.2009.01.002
2. Bagot, R. C., Tse, Y. C., Nguyen, H. B., Wong, A. S., Meaney, M. J., and Wong, T. P. (2012). Maternal care influences hippocampal N-methyl-D-aspartate receptor function and dynamic regulation by corticosterone in adulthood.Biol. Psychiatry 72, 491-498. doi: 10.1016/j.biopsych.2012.03.016
3. Bhardwaj, S. K., Baharnoori, M., Sharif-Askari, B., Kamath, A., Williams, S., and Srivastava, L. K. (2009). Behavioral characterization of dysbindin-1 deficient sandy mice. Behav. Brain Res. 197, 435-441. doi: 10.1016/j.bbr.2008.10.011
4. Bhardwaj, S. K., Tse, Y. C., Ryan, R., Wong, T. P., and Srivastava, L. K. (2014). Impaired adrenergic-mediated plasticity of prefrontal cortical glutamate synapses in rats with developmental disruption of the ventral hippocampus. Neuropsychopharmacology 39, 2963-2973. doi: 10.1038/npp.2014.142
5. Braunewell, K. H., and Manahan-Vaughan, D. (2001). Long-term depression: a cellular basis for learning? Rev. Neurosci. 12, 121-140. doi: 10.1515/revneuro.2001.12.2.121
6. Burdick, K. E., Goldberg, T. E., Funke, B., Bates, J. A., Lencz, T., Kucherlapati, R., et al. (2007). DTNBP1 genotype influences cognitive decline in schizophrenia. Schizophr. Res. 89, 169-172. doi: 10.1016/j.schres.2006.09.008
7. Conn, P. J., Lindsley, C. W., and Jones, C. K. (2009). Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia. Trends Pharmacol. Sci. 30, 25-31. doi: 10.1016/j.tips.2008.10.006
8. Conquet, F., Bashir, Z. I., Davies, C. H., Daniel, H., Ferraguti, F., Bordi, F., et al. (1994). Motor deficit and impairment of synaptic plasticity in mice lacking mGluR1. Nature 372, 237-243. doi: 10.1038/372237a0
9. Cox, M. M., Tucker, A. M., Tang, J., Talbot, K., Richer, D. C., Yeh, L., et al. (2009). Neurobehavioral abnormalities in the dysbindin-1 mutant, sandy, on a C57BL/6J genetic background. Genes Brain Behav. 8, 390-397. doi: 10.1111/j.1601-183x.2009.00477.x
10. Coyle, J. T. (2012). NMDA Receptor and schizophrenia: a brief history. Schizophr. Bull. 38, 920-926. doi: 10.1093/schbul/sbs076
11. Dhami, G. K., and Ferguson, S. S. G. (2006). Regulation of metabotropic glutamate receptor signaling, desensitization and endocytosis. Pharmacol. Ther. 111, 260-271. doi: 10.1016/j.pharmthera.2005.01.008
12. D'Hooge, R., and De Deyn, P. P. (2001). Applications of the Morris water maze in the study of learning and memory.Brain Res. Brain Res. Rev. 36, 60-90. doi: 10.1016/s0165-0173(01)00067-4
13. Ennaceur, A. (2010). One-trial object recognition in rats and mice: methodological and theoretical issues. Behav. Brain Res. 215, 244-254. doi: 10.1016/j.bbr.2009.12.036
14. Fallgatter, A. J., Ehlis, A. C., Herrmann, M. J., Hohoff, C., Reif, A., Freitag, C. M., et al. (2010). DTNBP1 (dysbindin) gene variants modulate prefrontal brain function in schizophrenic patients-support for the glutamate hypothesis of schizophrenias. Genes Brain Behav. 9, 489-497. doi: 10.1111/j.1601-183x.2010.00574.x
15. Ferraguti, F., Crepaldi, L., and Nicoletti, F. (2008). Metabotropic glutamate 1 receptor: current concepts and perspectives. Pharmacol. Rev. 60, 536-581. doi: 10.1124/pr.108.000166
16. Fowler, S. W., Ramsey, A. K., Walker, J. M., Serfozo, P., Olive, M. F., Schachtman, T. R., et al. (2011). Functional interaction of mGlu5 and NMDA receptors in aversive learning in rats. Neurobiol. Learn. Mem. 95, 73-79. doi: 10.1016/j.nlm.2010.11.009
17. Fowler, S. W., Walker, J. M., Klakotskaia, D., Will, M. J., Serfozo, P., Simonyi, A., et al. (2013). Effects of a metabotropic glutamate receptor 5 positive allosteric modulator, CDPPB, on spatial learning task performance in rodents. Neurobiol. Learn. Mem. 99, 25-31. doi: 10.1016/j.nlm.2012.10.010
18. Gallagher, S. M., Daly, C. A., Bear, M. F., and Huber, K. M. (2004). Extracellular signal-regulated protein kinase activation is required for metabotropic glutamate receptor-dependent long-term depression in hippocampal area CA1. J. Neurosci. 24, 4859-4864. doi: 10.1523/jneurosci.5407-03.2004
19. Ghiani, C. A., Starcevic, M., Rodriguez-Fernandez, I. A., Nazarian, R., Cheli, V. T., Chan, L. N., et al. (2010). The dysbindin-containing complex (BLOC-1) in brain: developmental regulation, interaction with SNARE proteins and role in neurite outgrowth. Mol. Psychiatry 115, 204-215. doi: 10.1038/mp.2009.58
20. Gladding, C. M., Fitzjohn, S. M., and Molnár, E. (2009). Metabotropic glutamate receptor-mediated long-term depression: molecular mechanisms. Pharmacol. Rev. 61, 395-412. doi: 10.1124/pr.109.001735
21. Guo, A. Y., Sun, J., Riley, B. P., Thiselton, D. L., Kendler, K. S., and Zhao, Z. (2009). The dystrobrevin-binding protein 1 gene: features and networks. Mol. Psychiatry 14, 18-29. doi: 10.1038/mp.2008.88
22. Hattori, S., Murotani, T., Matsuzaki, S., Ishizuka, T., Kumamoto, N., Takeda, M., et al. (2008). Behavioral abnormalities and dopamine reductions in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia. Biochem. Biophys. Res. Commun. 373, 298-302. doi: 10.1016/j.bbrc.2008.06.016
23. Homayoun, H., and Moghaddam, B. (2010). Group 5 metabotropic glutamate receptors: role in modulating cortical activity and relevance to cognition. Eur. J. Pharmacol. 639, 33-39. doi: 10.1016/j.ejphar.2009.12.042
24. Jentsch, J. D., Trantham-Davidson, H., Jairl, C., Tinsley, M., Cannon, T. D., and Lavin, A. (2009). Dysbindin modulates prefrontal cortical glutamatergic circuits and working memory function in mice.Neuropsychopharmacology 34, 2601-2608. doi: 10.1038/npp.2009.90
25. Ji, Y., Yang, F., Papaleo, F., Wang, H. X., Gao, W. J., Weinberger, D. R., et al. (2009). Role of dysbindin in dopamine receptor trafficking and cortical GABA function. Proc. Natl. Acad. Sci. U S A 106, 19593-19598. doi: 10.1073/pnas.0904289106
26. Kalkstein, S., Hurford, I., and Gur, R. C. (2010). Neurocognition in schizophrenia. Curr. Top. Behav. Neurosci. 4, 373-390. doi: 10.1007/7854_2010_42
27. Karlsgodt, K. H., Robleto, K., Trantham-Davidson, H., Jairl, C., Cannon, T. D., Lavin, A., et al. (2011). Reduced dysbindin expression mediates N-methyl-D-aspartate receptor hypofunction and impaired working memory performance. Biol. Psychiatry 69, 28-34. doi: 10.1016/j.biopsych.2010.09.012
28. Kemp, A., and Manahan-Vaughan, D. (2004). Hippocampal long-term depression and long-term potentiation encode different aspects of novelty acquisition. Proc. Natl. Acad. Sci. U S A 101, 8192-8197. doi: 10.1073/pnas.0402650101
29. Kim, S. H., Markham, J. A., Weiler, I. J., and Greenough, W. T. (2008). Aberrant early-phase ERK inactivation impedes neuronal function in fragile X syndrome. Proc. Natl. Acad. Sci. U S A 105, 4429-4434. doi: 10.1073/pnas.0800257105
30. Li, W., Zhang, Q., Oiso, N., Novak, E. K., Gautam, R., O'brien, E. P., et al. (2003). Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1). Nat. Genet. 35, 84-89. doi: 10.1038/ng1229
31. Liu, F., Grauer, S., Kelley, C., Navarra, R., Graf, R., Zhang, G., et al. (2008). ADX47273 [S-(4-Fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activities. J. Pharmacol. Exp. Ther. 327, 827-839. doi: 10.1124/jpet.108.136580
32. Lu, Y. M., Jia, Z., Janus, C., Henderson, J. T., Gerlai, R., Wojtowicz, J. M., et al. (1997). Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP.J. Neurosci. 17, 5196-5205.
33. Mukherjee, S., and Manahan-Vaughan, D. (2013). Role of metabotropic glutamate receptors in persistent forms of hippocampal plasticity and learning. Neuropharmacology 66, 65-81. doi: 10.1016/j.neuropharm.2012.06.005
34. Niswender, C. M., and Conn, P. J. (2010). Metabotropic glutamate receptors: physiology, pharmacology and disease. Annu. Rev. Pharmacol. Toxicol. 50, 295-322. doi: 10.1146/annurev.pharmtox.011008.145533
35. Papaleo, F., Yang, F., Garcia, S., Chen, J., Lu, B., Crawley, J. N., et al. (2012). Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways. Mol. Psychiatry 17, 85-98. doi: 10.1038/mp.2010.106
36. Patil, S. T., Zhang, L., Martenyi, F., Lowe, S. L., Jackson, K. A., Andreev, B. V., et al. (2007). Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial. Nat. Med. 13, 1102-1107. doi: 10.1038/nm1632
37. Popkirov, S. G., and Manahan-Vaughan, D. (2010). Involvement of the metabotropic glutamate receptor mGluR5 in NMDA receptor-dependent, learning-facilitated long-term depression in CA1 synapses. Cereb. Cortex 21, 501-509. doi: 10.1093/cercor/bhq093
38. Romano, C., Van Den Pol, A. N., and O'malley, K. L. (1996). Enhanced early developmental expression of the metabotropic glutamate receptor mGluR5 in rat brain: protein, mRNA splice variants, and regional distribution. J. Comp. Neurol. 367, 403-412. doi: 10.1002/(sici)1096-9861(19960408)367:3<403::aid-cne6>3.0.co;2-9
39. Straub, R. E., Jiang, Y., Maclean, C. J., Ma, Y., Webb, B. T., Myakishev, M. V., et al. (2002). Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am. J. Hum. Genet. 71, 337-348. doi: 10.1086/341750
40. Swank, R. T., Sweet, H. O., Davisson, M. T., Reddington, M., and Novak, E. K. (1991). Sandy: a new mouse model for platelet storage pool deficiency. Genet. Res. 58, 51-62. doi: 10.1017/s0016672300029608
41. Talbot, K., Ong, W. Y., Blake, D. J., Tang, J., Louneva, N., Carlson, G. C., et al. (2009). "Dysbindin-1 and its protein family," in Handbook of Neurochemistry and Molecular Neurobiology 3rd Edn. eds D. C. Javitt and J. Kantrowitz (New York: Springer Science), 107-241.
42. Tang, J., Legros, R. P., Louneva, N., Yeh, L., Cohen, J. W., Hahn, C. G., et al. (2009a). Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression. Hum. Mol. Genet. 18, 3851-3863. doi: 10.1093/hmg/ddp329
43. Tang, T. T., Yang, F., Chen, B. S., Lu, Y., Ji, Y., Roche, K. W., et al. (2009b). Dysbindin regulates hippocampal LTP by controlling NMDA receptor surface expression. Proc. Natl. Acad. Sci. U S A 106, 21395-21400. doi: 10.1073/pnas.0910499106
44. Uslaner, J. M., Parmentier-Batteur, S., Flick, R. B., Surles, N. O., Lam, J. S., Mcnaughton, C. H., et al. (2009). Dose-dependent effect of CDPPB, the mGluR5 positive allosteric modulator, on recognition memory is associated with GluR1 and CREB phosphorylation in the prefrontal cortex and hippocampus. Neuropharmacology 57, 531-538. doi: 10.1016/j.neuropharm.2009.07.022
45. Volk, D. W., Eggan, S. M., and Lewis, D. A. (2010). Alterations in metabotropic glutamate receptor 1alpha and regulator of G protein signaling 4 in the prefrontal cortex in schizophrenia. Am. J. Psychiatry 167, 1489-1498. doi: 10.1176/appi.ajp.2010.10030318
46. Weickert, C. S., Rothmond, D. A., Hyde, T. M., Kleinman, J. E., and Straub, R. E. (2008). Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients. Schizophr. Res. 98, 105-110. doi: 10.1016/j.schres.2007.05.041
47. Wood, G. K., Quirion, R., and Srivastava, L. K. (2003). Early environment contributes to developmental disruption of MPFC after neonatal ventral hippocampal lesions in rats. Synapse 50, 223-232. doi: 10.1002/syn.10265
48. Young, J. W., Powell, S. B., Risbrough, V., Marston, H. M., and Geyer, M. A. (2009). Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia. Pharmacol. Ther. 122, 150-202. doi: 10.1016/j.pharmthera.2009.02.004
49. Zhang, J. P., Burdick, K. E., Lencz, T., and Malhotra, A. K. (2010). Meta-analysis of genetic variation in DTNBP1 and general cognitive ability. Biol. Psychiatry 68, 1126-1133. doi: 10.1016/j.biopsych.2010.09.016